CMMB
Price
$1.16
Change
+$0.01 (+0.87%)
Updated
Jul 3 closing price
Capitalization
22.23M
33 days until earnings call
GLPG
Price
$28.83
Change
+$0.28 (+0.98%)
Updated
Jul 3 closing price
Capitalization
1.9B
17 days until earnings call
Interact to see
Advertisement

CMMB vs GLPG

Header iconCMMB vs GLPG Comparison
Open Charts CMMB vs GLPGBanner chart's image
Chemomab Therapeutics
Price$1.16
Change+$0.01 (+0.87%)
Volume$39.71K
Capitalization22.23M
Galapagos
Price$28.83
Change+$0.28 (+0.98%)
Volume$147.6K
Capitalization1.9B
CMMB vs GLPG Comparison Chart in %
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMMB vs. GLPG commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Hold and GLPG is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CMMB: $1.16 vs. GLPG: $28.83)
Brand notoriety: CMMB and GLPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 26% vs. GLPG: 44%
Market capitalization -- CMMB: $22.23M vs. GLPG: $1.9B
CMMB [@Biotechnology] is valued at $22.23M. GLPG’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 1 FA rating(s) are green whileGLPG’s FA Score has 0 green FA rating(s).

  • CMMB’s FA Score: 1 green, 4 red.
  • GLPG’s FA Score: 0 green, 5 red.
According to our system of comparison, both CMMB and GLPG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 3 TA indicator(s) are bullish while GLPG’s TA Score has 6 bullish TA indicator(s).

  • CMMB’s TA Score: 3 bullish, 6 bearish.
  • GLPG’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than CMMB.

Price Growth

CMMB (@Biotechnology) experienced а -2.82% price change this week, while GLPG (@Biotechnology) price change was +2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CMMB is expected to report earnings on Nov 07, 2025.

GLPG is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($1.9B) has a higher market cap than CMMB($22.2M). GLPG YTD gains are higher at: 4.836 vs. CMMB (-35.912). CMMB has higher annual earnings (EBITDA): -14.18M vs. GLPG (-127.75M). GLPG has more cash in the bank: 3.3B vs. CMMB (10.6M). CMMB has less debt than GLPG: CMMB (292K) vs GLPG (10.9M). GLPG has higher revenues than CMMB: GLPG (288M) vs CMMB (0).
CMMBGLPGCMMB / GLPG
Capitalization22.2M1.9B1%
EBITDA-14.18M-127.75M11%
Gain YTD-35.9124.836-743%
P/E RatioN/A53.70-
Revenue0288M-
Total Cash10.6M3.3B0%
Total Debt292K10.9M3%
FUNDAMENTALS RATINGS
CMMB vs GLPG: Fundamental Ratings
CMMB
GLPG
OUTLOOK RATING
1..100
5015
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
99100
SMR RATING
1..100
9891
PRICE GROWTH RATING
1..100
6350
P/E GROWTH RATING
1..100
10065
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMMB's Valuation (29) in the Biotechnology industry is somewhat better than the same rating for GLPG (73). This means that CMMB’s stock grew somewhat faster than GLPG’s over the last 12 months.

CMMB's Profit vs Risk Rating (99) in the Biotechnology industry is in the same range as GLPG (100). This means that CMMB’s stock grew similarly to GLPG’s over the last 12 months.

GLPG's SMR Rating (91) in the Biotechnology industry is in the same range as CMMB (98). This means that GLPG’s stock grew similarly to CMMB’s over the last 12 months.

GLPG's Price Growth Rating (50) in the Biotechnology industry is in the same range as CMMB (63). This means that GLPG’s stock grew similarly to CMMB’s over the last 12 months.

GLPG's P/E Growth Rating (65) in the Biotechnology industry is somewhat better than the same rating for CMMB (100). This means that GLPG’s stock grew somewhat faster than CMMB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMMBGLPG
RSI
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
74%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
65%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
60%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend about 1 month ago
78%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
66%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSPRX13.690.13
+0.96%
Voya Small Company Port R6
PFSVX14.150.11
+0.78%
iMGP Small Company Fund Instl Cl
GQLOX35.430.21
+0.60%
GMO Quality VI
OSCCX20.630.12
+0.59%
Invesco Main Street Small Cap C
PJERX14.990.04
+0.27%
PGIM Jennison Global Equity Income R

CMMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
+0.87%
AXON - CMMB
37%
Loosely correlated
+2.70%
OVID - CMMB
35%
Loosely correlated
+2.39%
COGT - CMMB
30%
Poorly correlated
+2.29%
MDGL - CMMB
29%
Poorly correlated
-0.43%
GLPG - CMMB
28%
Poorly correlated
+0.98%
More

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+0.98%
VCYT - GLPG
43%
Loosely correlated
N/A
RGNX - GLPG
38%
Loosely correlated
+1.39%
BEAM - GLPG
36%
Loosely correlated
+0.65%
AXON - GLPG
35%
Loosely correlated
+2.70%
IPSC - GLPG
33%
Poorly correlated
+0.02%
More